RNAZ (TransCode Therapeutics) Float Percentage Of Total Shares Outstanding: 100.03% (As of Jun. 28, 2026)


RNAZ TransCode Therapeutics Inc RNAZ
32 GF Score
Price $4.84
! 1 Warning Sign
View Full Analysis

What is TransCode Therapeutics Float Percentage Of Total Shares Outstanding?

TransCode Therapeutics RNAZ +10.69% 32 Float Percentage Of Total Shares Outstanding is 100.03% as of Jun. 28, 2026. GuruFocus rates RNAZ with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, TransCode Therapeutics's float shares is 0.95 Mil. TransCode Therapeutics's total shares outstanding is 0.95 Mil. TransCode Therapeutics's float percentage of total shares outstanding is 100.03%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, TransCode Therapeutics's Insider Ownership is 14.86%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, TransCode Therapeutics's Institutional Ownership is 3.37%.

RNAZ
32GF Score
TransCode Therapeutics Inc RNAZ
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TransCode Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

TransCode Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.95/0.95
=100.03%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 100.03% mean?
TransCode Therapeutics (RNAZ) has a Float Percentage Of Total Shares Outstanding of 100.03% as of Jun. 28, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on TransCode Therapeutics and its competitors.
Is TransCode Therapeutics' Float Percentage Of Total Shares Outstanding too high?
TransCode Therapeutics' current Float Percentage Of Total Shares Outstanding is 100.03%. Overall, TransCode Therapeutics has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does TransCode Therapeutics' Float Percentage Of Total Shares Outstanding compare to ARTL and GLMD?
TransCode Therapeutics' Float Percentage Of Total Shares Outstanding of 100.03% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on TransCode Therapeutics and its competitors. TransCode Therapeutics's current Float Percentage Of Total Shares Outstanding is 100.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TransCode Therapeutics stock overvalued right now?
TransCode Therapeutics (RNAZ) has a current Float Percentage Of Total Shares Outstanding of 100.03%. The current Float Percentage Of Total Shares Outstanding is 100.03%. TransCode Therapeutics' overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For TransCode Therapeutics (RNAZ), the current Float Percentage Of Total Shares Outstanding is 100.03% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TransCode Therapeutics Business Description

Address 6 Liberty Square, No. 2382, Boston, MA, USA, 02109
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.
32GF Score

Get the complete analysis for RNAZ

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.84
Price